Yong K. Kang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer.

Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer.

Journal: International journal of molecular medicine
Published: August 11, 2025

C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC.

C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC.

Journal: Oncology reports
Published: July 14, 2025

Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer.

Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer.

Journal: Experimental hematology & oncology
Published: April 14, 2025

The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer.

The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer.

Journal: Theranostics
Published: December 14, 2023

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 28, 2023

Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.

Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.

Journal: Clinical orthopaedics and related research
Published: April 14, 2020

Post-radiation sarcoma: A study by the Eastern Asian Musculoskeletal Oncology Group.

Post-radiation sarcoma: A study by the Eastern Asian Musculoskeletal Oncology Group.

Journal: PloS one
Published: February 03, 2018

Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study.

Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study.

Journal: Nutrients
Published: November 09, 2017

Retraction to: Memory-Enhancing Effects of Silk Fibroin-Derived Peptides in Scopolamine-Treated Mice.

Retraction to: Memory-Enhancing Effects of Silk Fibroin-Derived Peptides in Scopolamine-Treated Mice.

Journal: Journal of microbiology and biotechnology
Published: December 31, 2016

Prognostic significance of chemotherapy-induced necrosis in osteosarcoma patients receiving pasteurized autografts.

Prognostic significance of chemotherapy-induced necrosis in osteosarcoma patients receiving pasteurized autografts.

Journal: PloS one
Published: October 10, 2016

Memory-enhancing effects of silk fibroin-derived peptides in scopolamine-treated mice.

Memory-enhancing effects of silk fibroin-derived peptides in scopolamine-treated mice.

Journal: Journal of microbiology and biotechnology
Published: September 18, 2013

(E)-N-(3,3-Diphenyl-allyl-idene)-4-nitro-aniline.

(E)-N-(3,3-Diphenyl-allyl-idene)-4-nitro-aniline.

Journal: Acta crystallographica. Section E, Structure reports online
Published: September 17, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026